More SEC Filings
View Older Stories View Newer Stories-
Form 4 Synaptogenix, Inc. For: Apr 03 Filed by: SCHECHTER JONATHAN
-
Form ARS Star Holdings For: Dec 31
-
Form 497K PROSHARES TRUST
-
Form 425 Bukit Jalil Global Acqui Filed by: Bukit Jalil Global Acquisition 1 Ltd.
-
Form 424B2 BARCLAYS BANK PLC
-
Form 424B2 MORGAN STANLEY
-
Form 8-K TRANSCAT INC For: Apr 01
-
Form SCHEDULE 13D Local Bounti Corporation Filed by: Live Oak Ventures, LLC
-
Form D Eclipse SPV XXV, L.P.
-
Form 10-K/A Bancorp, Inc. For: Dec 31
-
Form POS AM Nikola Corp
-
Form 424B5 Traws Pharma, Inc.
-
Form 424B2 BANK OF NOVA SCOTIA
-
Form 424B2 ROYAL BANK OF CANADA
-
Form D Juxta Venture Partners
-
Form 424B3 Steakholder Foods Ltd.
-
Form 8-K ENTRAVISION COMMUNICATIO For: Apr 04
-
Form 6-K KINROSS GOLD CORP For: Apr 07
-
Form 8-K Bukit Jalil Global Acqui For: Apr 07
-
Form 8-K Bowman Consulting Group For: Apr 03
-
Form 4 Synaptogenix, Inc. For: Apr 03 Filed by: Bernstein Bruce
-
Form 8-K Eledon Pharmaceuticals, For: Apr 01
-
Form 485APOS Abacus FCF ETF Trust
-
Form 4 ENTRAVISION COMMUNICATIO For: Jan 21 Filed by: Christenson Michael J
-
Form 4 ENTRAVISION COMMUNICATIO For: Jan 21 Filed by: Navarro Juan
-
Form 4 ENTRAVISION COMMUNICATIO For: Jan 21 Filed by: Boelke Mark
-
Form 4 ENTRAVISION COMMUNICATIO For: Dec 20 Filed by: McNally William J
-
Form 4 AST SpaceMobile, Inc. For: Apr 06 Filed by: Wisniewski Scott
-
Form SCHEDULE 13G/A SURO CAPITAL CORP. Filed by: Thomas J. Herzfeld Advisors, Inc.
-
Form SCHEDULE 13G/A Saba Capital Income & Filed by: Thomas J. Herzfeld Advisors, Inc.
-
Form RW NextTrip, Inc.
-
Form 4 ENTRAVISION COMMUNICATIO For: Jan 21 Filed by: JEFFERY LIBERMAN A
-
Form 8-K WESTERN DIGITAL CORP For: Apr 07
-
Form 497 Texas Capital Funds Trus
-
Form 4 Karyopharm Therapeutics For: Apr 04 Filed by: Paulson Richard A.
-
Form 8-K Pacira BioSciences, Inc. For: Apr 07
-
Form 8-K ISABELLA BANK Corp For: Apr 04
-
Form ARS Alkermes plc. For: Dec 31
-
Form POS AM Nikola Corp
-
Form 424B2 MORGAN STANLEY
-
Form 424B2 MORGAN STANLEY
-
Form 20-F NeuroSense Therapeutics For: Dec 31
-
Form 424B2 GOLDMAN SACHS GROUP INC
-
Form SCHEDULE 13D/A ALTISOURCE PORTFOLIO Filed by: Credit Investments Group, a distinct business unit of UBS Asset Management (Americas) LLC
-
Form 4/A CONDUENT Inc For: Apr 01 Filed by: APPLEBY ADAM D
-
Form DEFA14A CROWN CASTLE INC.
-
Form POS AM Nikola Corp
-
Form 424B2 ROYAL BANK OF CANADA
-
Form 8-K FIRST CITIZENS BANCSHARE For: Apr 07
-
Form D/A Skaana Partners L.P.

